KLOW80 Blend

KLOW80 Blend – Multi-Peptide Research Formula

The KLOW80 Blend is an advanced multi-peptide research formula composed of four peptides: GHK-Cu (50 mg), TB-500 (10 mg), BPC-157 (10 mg), and KPV (10 mg). This formulation is supplied as a reagent for in-vitro research focused on cellular biochemistry, inflammation signaling, skin biochemistry, and collagen-associated activity.

Each component is manufactured under rigorous laboratory standards and verified through High-Performance Liquid Chromatography (HPLC) to ensure a purity level of ≥99%. The KLOW80 Blend provides a reproducible reference material for advanced biochemical and pharmacological studies.

Blend Composition

• GHK-Cu – 50 mg: Copper-binding peptide examined in studies relating to skin biochemistry, wound-model assays, and DNA-repair pathway research.
• TB-500 (Thymosin Beta-4 fragment) – 10 mg: Referenced in research exploring tissue-regeneration models, angiogenesis assays, and myogenic repair pathways.
• BPC-157 – 10 mg: Used as a reagent in in-vitro models of inflammation signaling, cell-repair mechanisms, and vascular growth factors.
• KPV – 10 mg: An α-MSH–derived peptide studied in anti-inflammatory peptide signaling pathway research.

Key Specifications

• Name: KLOW80 Blend
• Total Content: 80 mg (50 mg GHK-Cu, 10 mg TB-500, 10 mg BPC-157, 10 mg KPV)
• Type: Multi-Peptide Research Reagent Blend
• Form: Lyophilized Powder
• Purity: ≥99% (HPLC verified)
• Storage: Store refrigerated; protect from light and moisture
• Shelf life: Sealed lyophilizate. Shelf life 24 months from manufacture.

Research Applications

• Studied for combined effects on cell-repair signaling, anti-inflammatory pathways, and collagen-synthesis assays.
• Referenced in in-vitro models exploring skin biochemistry, vascular development, and regenerative peptide signaling.
• Formulated for consistency and reliability in controlled biochemical research environments.

A batch-specific Certificate of Analysis (CoA) is available on request and accompanies every order.